Home
Scholarly Works
Report of NRG Oncology/RTOG 9601, A Phase 3 Trial...
Conference

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

Authors

Shipley WU; Seiferheld W; Lukka H; Major P; Heney NM; Grignon D; Sartor O; Patel M; Bahary JP; Zietman AL

Volume

94

Publisher

Elsevier

Publication Date

January 1, 2016

DOI

10.1016/j.ijrobp.2015.10.048

Conference proceedings

International Journal of Radiation Oncology • Biology • Physics

Issue

1

ISSN

0360-3016

Contact the Experts team